Literature DB >> 7032946

The response to the angiotensin antagonist saralasin in predicting therapeutic outcome in hypertension treated with frusemide.

A Burke, C R George, E P MacCarthy, G S Stokes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7032946     DOI： 10.1007/bf00627914

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  Identification of angiotensinogenic hypertension in man using 1-sar-8-ala-angiotensin II (Saralasin, P-113).

Authors:  D H Streeten; J M Freiberg; G H Anderson; T G Dalakos
Journal:  Circ Res       Date:  1975-06       Impact factor: 17.367

2.  Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.

Authors:  J H Laragh
Journal:  Am J Med       Date:  1973-09       Impact factor: 4.965

Review 3.  Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture.

Authors:  J J Brown; J Casals-Stenzel; A M Cumming; D L Davies; R Fraser; A F Lever; J J Morton; P F Semple; M Tree; J I Robertson
Journal:  Hypertension       Date:  1979 May-Jun       Impact factor: 10.190

4.  Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone.

Authors:  J W Woods; A W Pittman; C C Pulliam; E E Werk; W Waider; C A Allen
Journal:  N Engl J Med       Date:  1976-05-20       Impact factor: 91.245

5.  False-negative saralasin responses in renovascular hypertension.

Authors:  G S Stokes; E P MacCarthy; G W Frost; A G Sheil
Journal:  Br J Urol       Date:  1979-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.